ADMA Biologics ADMA Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ADMA Biologics's change in AP?
- ADMA Biologics (ADMA) reported change in AP of -$1.23M in Q1 2026.
- How has ADMA Biologics's change in AP changed year-over-year?
- ADMA Biologics's change in AP decreased by 968.3% year-over-year, from $142K to -$1.23M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.